F. Costa

发表

Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.

N. Colombo, C. Jommi, P. Armeni, 2020 .

Health care costs of influenza-related episodes in high income countries: A systematic review

C. Federici, C. Jommi, Francesco Costa, 2018, PloS one.

Use of Resource Modeling to Quantify the Organizational Impact of Subcutaneous Formulations for the Treatment of Oncologic Patients: The Case of Daratumumab in Multiple Myeloma.

C. Federici, P. Armeni, C. Rognoni, 2022, Clinical therapeutics.

Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies.

A. Torbica, O. Ciani, H. Banks, 2021, Health policy.

The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis

L. Ferini-Strambi, G. Donin, P. Armeni, 2022, PloS one.

Final report Cost-of-illness study of Obstructive Sleep Apnea Syndrome (OSAS) in Italy

G. Donin, P. Armeni, Ludovica Borsoi, 2019 .

Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy

P. Armeni, C. Rognoni, C. Falivena, 2023, PharmacoEconomics.

Implementation of Value-based Pricing for Medicines.

C. Jommi, P. Armeni, Francesco Costa, 2019, Clinical therapeutics.

Economic impact of a more extensive use of FENO testing on the Italian population with asthma

M. Bonini, G. E. Carpagnano, L. Brussino, 2023, Respiratory Research.

Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.

F. Grossi, C. Jommi, P. Armeni, 2020 .

Pharmaceutical pricing and managed entry agreements: an exploratory study on future perspectives in Europe

C. Jommi, P. Armeni, A. Bertolani, 2023, Health Policy and Technology.

Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case

C. Jommi, P. Armeni, M. Otto, 2023, Journal of Pharmaceutical Policy and Practice.

Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention

M. Valgimigli, P. Armeni, C. Rognoni, 2023, Expert review of pharmacoeconomics & outcomes research.

Elicitation of societal preferences for chronic lymphocytic leukemia's treatments: a discrete choice experiment.

P. Ghia, P. Armeni, Ludovica Borsoi, 2024, Leukemia & lymphoma.

The future of Funds for Innovative Medicines: results from a Delphi Study

C. Jommi, P. Armeni, A. Bertolani, 2021, Global & regional health technology assessment.